Skip to content

PTC Therapeutics

US · PTCT #2071 by market cap Listed 1970
56.42 -1.91 -3.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About PTC Therapeutics

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Founded
1998
CEO
Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
Employees
1,047
Headquarters
Warren, New Jersey, United States of America
Fiscal year end
12-31
Website
ptcbio.com

Company profile

Exchange
US
Symbol
PTCT
Market-cap rank
#2071
Listing date
1970-01-01
Market cap
4.71B
Float cap
4.60B
Shares out
83.54M
Float shares
81.52M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

PTC Therapeutics discussion 0 comments

Add a comment